MAY 31, 2019
Ingrid A Binswanger, MD, MPH, MS
Senior Investigator, Institute for Health Research, Kaiser Permanente Colorado
Chemical Dependency Treatment Services, Colorado Permanente Medical Group
About the Presentation: The presentation will focus on the (1) challenges to expanding naloxone access to patients prescribed opioids, (2) how opioid analgesic dose and dose modifications are associated with both pharmaceutical opioid and heroin overdose, and (3) benefits and harms of tapering opioids among individuals prescribed opioids.
About the Presenter: Ingrid A. Binswanger, MD, MPH, MS is a Senior Investigator at the Institute for Health Research at Kaiser Permanente Colorado and an Associate Professor of Medicine at the University of Colorado School of Medicine. Dr. Binswanger’s research focuses on novel approaches to preventing deaths from opioid overdose in health system, criminal justice, and community settings. She currently conducts research on expanding access to naloxone and the intended and unintended consequences of restrictive opioid management practices in primary care. Dr. Binswanger’s research has been funded by the National Institute on Drug Abuse, the Department of Justice, and the Centers for Disease Control and Prevention. She also provides clinical care for patients who use substances with the Colorado Permanente Medical Group.